Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.

PubWeight™: 13.91‹?› | Rank: Top 0.1% | All-Time Top 10000

🔗 View Article (PMID 19272486)

Published in Am J Med on March 01, 2009

Authors

Henry Buchwald1, Rhonda Estok, Kyle Fahrbach, Deirdre Banel, Michael D Jensen, Walter J Pories, John P Bantle, Isabella Sledge

Author Affiliations

1: Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA. buchw001@umn.edu

Associated clinical trials:

Safety and Efficacy of Long Limb Roux-en Y Reconstruction (LoLiRoRe) | NCT01373346

Caloric Restriction and Insulin Secretion | NCT01447524

Metabolic Impact of Dietary Protein Supplementation in Surgical Weight Loss (MIPS) | NCT02269410

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D) | NCT02328599

Intraluminal Imaging of Duodenal Layer Morphometry in Patients With and Without Type 2 Diabetes | NCT02688920

Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment | NCT02041234

Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding | NCT01597531

Bariatric Surgery Study (SIBS) | NCT03766360

Articles citing this

(truncated to the top 100)

Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85

Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28

Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care (2012) 21.62

Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66

Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78

Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med (2012) 13.59

Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71

Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA (2012) 5.15

Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial. JAMA Surg (2015) 3.67

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes (2010) 3.39

Health benefits of gastric bypass surgery after 6 years. JAMA (2012) 3.10

A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg (2013) 3.06

The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg (2014) 2.91

Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med (2011) 2.74

Clinical Benefit of Gastric Staple Line Reinforcement (SLR) in Gastrointestinal Surgery: a Meta-analysis. Obes Surg (2015) 2.23

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) (2013) 2.22

Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes (2013) 2.19

Gastric bypass and banding equally improve insulin sensitivity and β cell function. J Clin Invest (2012) 2.19

Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia. Gut (2013) 2.18

Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery. Lancet Diabetes Endocrinol (2014) 2.16

Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care (2012) 2.08

Type 2 diabetes: prevention and cure? Br J Gen Pract (2013) 2.04

Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes Care (2014) 2.04

Prevalence of alcohol use disorders before and after bariatric surgery. JAMA (2012) 2.02

Metabolic surgery for type 2 diabetes with BMI <35 kg/m(2) : an endocrinologist's perspective. Obes Surg (2013) 2.00

Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg (2013) 1.91

Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006. Obes Surg (2011) 1.85

Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care (2013) 1.83

All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev (2012) 1.74

Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol (2011) 1.68

Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care (2012) 1.66

Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res (2013) 1.65

Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol (2015) 1.64

Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab (2011) 1.63

Effects of gastric bypass surgery on female reproductive function. J Clin Endocrinol Metab (2012) 1.63

Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass. Clin Gastroenterol Hepatol (2010) 1.60

GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats. Diabetes (2013) 1.58

Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg (2009) 1.56

Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg (2015) 1.55

Role of the glucagon-like-peptide-1 receptor in the control of energy balance. Physiol Behav (2010) 1.54

Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med (2010) 1.54

Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI <35: an analysis of 454 consecutive patients. World J Surg (2011) 1.52

Thermogenic changes after gastric bypass, adjustable gastric banding or diet alone. Surgery (2014) 1.48

Bariatric surgery: a systematic review of the clinical and economic evidence. J Gen Intern Med (2011) 1.45

Retracted Effects of bariatric surgery on incidence of obesity-related cancers: a meta-analysis. Med Sci Monit (2015) 1.44

Prospective randomized clinical trial of laparoscopic sleeve gastrectomy versus open Roux-en-Y gastric bypass for the management of patients with morbid obesity. Wideochir Inne Tech Maloinwazyjne (2012) 1.42

Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism (2011) 1.41

Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol (2015) 1.41

Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res (2010) 1.41

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract (2013) 1.40

Metabolic syndrome and the hepatorenal reflex. Surg Neurol Int (2016) 1.40

Prevalence and characteristics of individuals without diabetes and hypertension who underwent bariatric surgery: lessons learned about metabolically healthy obese. Surg Obes Relat Dis (2014) 1.39

Diabetes Remission after Nonsurgical Intensive Lifestyle Intervention in Obese Patients with Type 2 Diabetes. J Diabetes Res (2015) 1.39

Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS One (2010) 1.38

Objective quantification of physical activity in bariatric surgery candidates and normal-weight controls. Surg Obes Relat Dis (2009) 1.37

Public health campaigns and obesity - a critique. BMC Public Health (2011) 1.35

Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33

Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care (2011) 1.31

The effects of vertical sleeve gastrectomy in rodents are ghrelin independent. Gastroenterology (2012) 1.28

Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care (2010) 1.25

Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes Surg (2011) 1.25

Bariatric surgery. Dtsch Arztebl Int (2011) 1.23

Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care (2012) 1.22

The long-term effectiveness of a lifestyle intervention in severely obese individuals. Am J Med (2013) 1.22

Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol (2013) 1.21

Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care (2011) 1.21

Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes. J Clin Endocrinol Metab (2010) 1.20

Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI ≥35 kg/m². Obesity (Silver Spring) (2010) 1.19

An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss. Genome Biol (2015) 1.19

Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans. Gastroenterology (2012) 1.19

Short-term insulin requirements following gastric bypass surgery in severely obese women with type 1 diabetes. Obes Surg (2014) 1.18

Type 2 diabetes as a disease of ectopic fat? BMC Med (2014) 1.17

Changes in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: a pilot study. PLoS One (2011) 1.17

Body composition and energy metabolism following Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) (2010) 1.16

Similar effects of roux-en-Y gastric bypass and vertical sleeve gastrectomy on glucose regulation in rats. Physiol Behav (2011) 1.15

Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Can J Surg (2013) 1.15

Risk for hospital readmission following bariatric surgery. PLoS One (2012) 1.14

Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss. Obesity (Silver Spring) (2011) 1.14

Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol (2012) 1.14

Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care (2011) 1.13

Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg (2011) 1.13

Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg (2014) 1.12

Evidence-based German guidelines for surgery for obesity. Int J Colorectal Dis (2011) 1.12

Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus. Indian J Endocrinol Metab (2012) 1.12

Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care (2012) 1.12

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care (2015) 1.10

Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes. BMC Med (2013) 1.10

Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia (2016) 1.09

Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients. Diabetes (2013) 1.09

Impact of bariatric surgery on life expectancy in severely obese patients with diabetes: a decision analysis. Ann Surg (2015) 1.08

Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery. Surg Endosc (2012) 1.06

Emerging treatment options for type 2 diabetes. Br J Clin Pharmacol (2010) 1.06

The great debate: medicine or surgery: what is best for the patient with type 2 diabetes? Diabetes Care (2011) 1.06

First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc (2011) 1.06

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes (2014) 1.05

Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity. Br J Gen Pract (2013) 1.04

Changes in taste perception and eating behavior after bariatric surgery-induced weight loss in women. Obesity (Silver Spring) (2013) 1.02

Tackling obesity in knee osteoarthritis. Nat Rev Rheumatol (2012) 1.02

Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes (2013) 1.01

Articles by these authors

Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care (2008) 9.34

DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med (2006) 7.90

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet (2006) 6.50

Interindividual variation in posture allocation: possible role in human obesity. Science (2005) 6.26

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol (2013) 5.24

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care (2002) 4.46

Splanchnic lipolysis in human obesity. J Clin Invest (2004) 3.94

Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery. Surg Obes Relat Dis (2007) 3.67

Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA (2013) 3.57

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA (2013) 3.49

Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34

Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol (2009) 3.09

Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab (2006) 3.03

Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71

Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes (2003) 2.53

The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46

Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38

Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrinol Metab (2002) 2.38

Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery (2007) 2.35

Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31

Meta-analysis of alignment outcomes in computer-assisted total knee arthroplasty surgery. J Arthroplasty (2007) 2.26

Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) (2008) 2.23

Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol (2002) 2.23

Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A (2010) 2.17

Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab (2004) 2.16

Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab (2002) 2.13

Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res (2008) 2.02

Prevalence of alcohol use disorders before and after bariatric surgery. JAMA (2012) 2.02

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf (2010) 1.95

Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res (2003) 1.92

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care (2003) 1.91

Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes (2007) 1.88

Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Mol Genet Metab (2007) 1.86

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. Chest (2004) 1.80

Subcutaneous adipocyte size and body fat distribution. Am J Clin Nutr (2008) 1.80

Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care (2003) 1.78

Nutrition principles and recommendations in diabetes. Diabetes Care (2004) 1.78

Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol (2009) 1.77

Two-year outcome of a combination of weight loss therapies for type 2 diabetes. Diabetes Care (2005) 1.68

Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association. Diabetes Care (2006) 1.65

Relationship between surgeon volume and adverse outcomes after RYGB in Longitudinal Assessment of Bariatric Surgery (LABS) study. Surg Obes Relat Dis (2009) 1.63

Mechanism for improved insulin sensitivity after gastric bypass surgery. J Clin Endocrinol Metab (2008) 1.62

Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest (2003) 1.62

A quick, reliable, and automated method for fat cell sizing. J Lipid Res (2003) 1.61

Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology (2012) 1.57

Storage of circulating free fatty acid in adipose tissue of postabsorptive humans: quantitative measures and implications for body fat distribution. Diabetes (2011) 1.53

Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MS. J Lipid Res (2010) 1.50

Body mass index and outcomes in critically injured blunt trauma patients: weighing the impact. J Am Coll Surg (2007) 1.49

Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res (2006) 1.48

Ethnic differences in adiponectin levels. Metabolism (2004) 1.45

Acute changes in lipoprotein subclasses during exercise. Metabolism (2013) 1.45

Relationship between plasma free fatty acid, intramyocellular triglycerides and long-chain acylcarnitines in resting humans. J Physiol (2009) 1.41

Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes (2002) 1.40

Scientific data from clinical trials: investigators' responsibilities and rights. Surg Endosc (2002) 1.39

Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology (2006) 1.39

Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res (2005) 1.38

The ASBS Bariatric Surgery Centers of Excellence program: a blueprint for quality improvement. Surg Obes Relat Dis (2006) 1.37

Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obesity (Silver Spring) (2010) 1.37

Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis (2008) 1.37

Why are we shaped differently, and why does it matter? Am J Physiol Endocrinol Metab (2008) 1.35

Nonoxidative free fatty acid disposal is greater in young women than men. J Clin Endocrinol Metab (2010) 1.31

Fat depots, free fatty acids, and dyslipidemia. Nutrients (2013) 1.30

Effect of weight loss on muscle lipid content in morbidly obese subjects. Am J Physiol Endocrinol Metab (2002) 1.27

Sex-specific differences in leg fat uptake are revealed with a high-fat meal. Am J Physiol Endocrinol Metab (2006) 1.25

Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol (2004) 1.24

Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J (2008) 1.24

Basal and insulin-regulated free fatty acid and glucose metabolism in humans. Am J Physiol Endocrinol Metab (2007) 1.24

Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg (2010) 1.23

Preventing overestimation of pixels in computed tomography assessment of visceral fat. Obes Res (2004) 1.22

Plasma free fatty acid storage in subcutaneous and visceral adipose tissue in postabsorptive women. Diabetes (2008) 1.22

Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab (2002) 1.21

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflammation (2006) 1.20

Strength training and adiposity in premenopausal women: strong, healthy, and empowered study. Am J Clin Nutr (2007) 1.20

Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care (2007) 1.20

Meal fatty acid uptake in visceral fat in women. Diabetes (2007) 1.20

Leptin upregulates caveolin-1 expression: implications for development of atherosclerosis. Atherosclerosis (2010) 1.19

Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. Am J Physiol Regul Integr Comp Physiol (2004) 1.16

Counterpoint: visceral adiposity is not causally related to insulin resistance. Diabetes Care (2005) 1.15

Single-gene detection and karyotyping using small-target fluorescence in situ hybridization on maize somatic chromosomes. Genetics (2007) 1.13

GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)? Obes Surg (2012) 1.13

The influence of sex and obesity phenotype on meal fatty acid metabolism before and after weight loss. Am J Clin Nutr (2008) 1.13

Visceral and subcutaneous adipose tissue diacylglycerol acyltransferase activity in humans. Obesity (Silver Spring) (2009) 1.12

Minimally invasive colorectal resection outcomes: short-term comparison with open procedures. J Am Coll Surg (2006) 1.10

A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans. Rapid Commun Mass Spectrom (2012) 1.10

Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. J Clin Endocrinol Metab (2011) 1.10

Sex differences in abdominal, gluteal, and thigh LPL activity. Am J Physiol Endocrinol Metab (2007) 1.10

Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins. Diabetes (2011) 1.09

Reduced glycemic index and glycemic load diets do not increase the effects of energy restriction on weight loss and insulin sensitivity in obese men and women. J Nutr (2005) 1.08